Announcing Winner of the 2019 Servier Golden Ticket
The 2019 Servier Golden Ticket at MBC BioLabs has been awarded to Quartz Therapeutics.
ViewPoint
ViewPoint develops a nonsurgical route to cataract treatment.
Apply for the 2019 AMGEN Golden Ticket by 5/3/2019!
AMGEN and MBC BioLabs invite you to apply for the 2019 AMGEN Golden Ticket!
Alector
Alector raised $185 million in IPO
MBC BioLab’s first company, Alector, is getting ready to go public
Alector moved into MBC BioLabs on the day we opened our doors, and now just over five years later they have two programs in the clinic, a partnership with AbbVie, and are now are preparing to g [...]
Cypre and Molecular Devices sign co-marketing agreement to collaborate on delivering solutions for screening biologically relevant assays
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cypre and Molecular Devices signed a co-marketing agreement to jointly market Cypre’s Symphony®/VersaGel® 3D cel [...]